45 minutes
Shifting the Drug Industry’s Public Narrative Through Stories of Success The COVID-19 pandemic has put a spotlight on the true value of the life sciences industry – every person in the world now knows what it feels like to live with an unmet medical need. Will this have a lasting impact on the reputation of the industry? This panel will address the evolving public opinion about drug prices, innovation, and the industry, and how first-hand experience of patients, employees, and physicians could be a critical piece of reframing the debate.


David P. Meeker MD - President & CEO, Rhythm Pharmaceuticals
Mike Nikitas - Founder | Nikitas Communications
Nancy Simonian - CEO, Syros
Pam Randhawa - Founder & Chief Executive Officer, Empiriko & Chair, MassBio Board
Name Audience
Conference Wide